Get short, timely messages from PharmaCertify.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @PharmaCertify.

Get updates via SMS by texting follow PharmaCertify to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

PharmaCertify

  1. Brazilian Congress considers foreign bribery bill. bit.ly/KPabQI
  2. Grassley questions NIH over $400K research grant given to doc under investigation by OIG and DOJ. bit.ly/JA4Zl0
  3. Study finds spend disclosure laws have no effect on prescribing habits. bit.ly/KqpUGA
  4. Week in Review, May 25, 2012 wp.me/pPj6b-73
  5. Survey finds the number of top executives willing to pay bribes to secure business is on the rise. reut.rs/Kdnjy4 #antibribery
  6. In and Out Amendment. bit.ly/Jvw1ev Amendment to repeal med device tax withdrawn.
  7. HHS Inspector General Daniel R. Levinson speaks at the Health Care Compliance Association’s Compliance Institute. go.usa.gov/pPB
  8. Study finds docs who prohibit, limit rep visits are slower to drop black box warning drugs and adopt new therapies. on.mktw.net/KOyfko
  9. Week in Review, May 18, 2012 wp.me/pPj6b-6Y
  10. “Disclosure is not a magic bullet,” bloom.bg/JxAPQ4 Why self-disclosure of potential FCPA violations may not be prudent.
  11. Enforcement of federal and state False Claims Acts remains trendy in healthcare fraud enforcement. bit.ly/MgbrhI
  12. Grassley disappointed with CMS postponing Sunshine data collection. bit.ly/KaL4n4 No excuses if they can’t get it right.
  13. Week in Review, May 11, 2012 wp.me/pPj6b-6U
  14. Question of who qualifies as a foreign offical under the FCPA reaches appelate court. on.wsj.com/KVHrC4
  15. European patient group angry that use of drugs for off-label treatment does not require written consent from patients. bit.ly/JijKJZ
  16. Whistleblowers in Abbott case to share $84million. bit.ly/K4bBUK Second largest payout since False Claims Act revised in 1986.
  17. Anti-corruption and transparency are hot topics at International Medical Device Industry Compliance Conference. bit.ly/ICUWHQ
  18. States tout their portion of Abbot settlement here, tnne.ws/KCeeCo here bit.ly/JdgGcA and here bit.ly/K7iNn5
  19. Abbott Labs to pay $1.5 Billion to resolve off-label marketing investigation. 1.usa.gov/KfuENP
  20. Oregon settles with Abbott for $3.9M in off-label marketing case. bit.ly/KPANQo